Regarding the chemical class of GIGYF2 inhibitors, these are not direct inhibitors but rather a collection of compounds that may affect GIGYF2 function through indirect means. The chemical class is diverse, reflecting the various pathways that intersect with GIGYF2's roles in insulin signaling and mRNA translation control. These compounds have mechanisms of action that include inhibition of key kinases in the insulin signaling pathway (such as PI3K and AKT), interference with the downstream mTOR signaling pathway, disruption of the protein synthesis machinery, and alteration of gene expression that may affect the regulatory roles of GIGYF2.
These indirect GIGYF2 inhibitors target processes that are either upstream or downstream of GIGYF2's known activities, with the potential to alter the protein's interaction with other signaling molecules or its ability to regulate mRNA translation. By affecting these pathways, such compounds may alter the functional context in which GIGYF2 operates, thereby modulating its activity. The compounds listed could be considered for experimental studies to delineate GIGYF2's role in cellular processes and to understand how perturbations in related pathways can influence its function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor that would similarly impact GIGYF2 function indirectly through insulin signaling. | ||||||
MK-2206 dihydrochloride | 1032350-13-2 | sc-364537 sc-364537A | 5 mg 10 mg | $182.00 $332.00 | 67 | |
An allosteric inhibitor of AKT, which is downstream of PI3K and may influence GIGYF2-mediated processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a downstream component of insulin signaling, potentially affecting GIGYF2's role in mRNA translation. | ||||||
PP242 | 1092351-67-1 | sc-301606A sc-301606 | 1 mg 5 mg | $57.00 $172.00 | 8 | |
An mTOR kinase inhibitor that would impact multiple downstream processes including those associated with GIGYF2. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by interfering with the translocation step in the ribosome, potentially impacting GIGYF2-related translation control. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Causes premature chain termination during translation, which could influence GIGYF2's regulatory roles. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor that could affect the expression of genes including those involved in GIGYF2 pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
An HDAC inhibitor that could alter gene expression profiles and potentially impact GIGYF2 function. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
A cyclin-dependent kinase inhibitor that may alter cell cycle progression and indirectly affect GIGYF2's interaction with cell cycle regulators. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of JNK, which could affect various signaling pathways, including those related to GIGYF2's functions. | ||||||